Mereo BioPharma Group plc American Depositary Shares (MREO) is a publicly traded Healthcare sector company. As of November 9, 2026, MREO trades at $0.29 with a market cap of $45.19M and a P/E ratio of -7.80. MREO moved +0.00% today. Year to date, MREO is -44.55%; over the trailing twelve months it is -83.92%. Its 52-week range spans $0.20 to $3.05. Analyst consensus is neutral with an average price target of $3.00. Rallies surfaces MREO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MREO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.29 |
| Market Cap | $45.19M |
| P/E Ratio | -7.80 |
| EPS | $-0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.05 |
| 52-Week Low | $0.20 |
| Volume | 35.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $500.00K |
| Net Income | $-41.88M |
| Gross Margin | 0.00% |
4 analysts cover MREO: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.00.